IDH mutations have been implicated in other cancer types, including AML, myelodysplastic syndrome (15–18), cholangiocarcinoma of intrahepatic origin (53), central and periosteal cartilaginous chondrosarcomas (54), and melanoma (55, 56). The gene discussed is IDH1; the disease is acute myeloid leukemia.